Benign Prostatic Hyperplasia (BPH) is one of the most common progressive conditions affecting aging men. When medical therapies such as alpha-blockers or 5-alpha reductase inhibitors fail to provide adequate relief or cause intolerable side effects, surgical intervention becomes the definitive pathway.
In metropolitan medical hubs like Incheon, advanced surgical modalities allow patients to receive hospital-grade procedures with minimized downtime. Choosing the right intervention requires an understanding of prostate anatomy, volumetric thresholds, and functional preservation goals.
1. Clinical Indications: When Is BPH Surgery Necessary?
Surgical intervention is indicated when conservative medical management no longer preserves lower urinary tract function or when severe complications arise.
- Refractory Urinary Retention: Recurrent episodes of acute retention requiring catheterization.
- Severe Lower Urinary Tract Symptoms (LUTS): An International Prostate Symptom Score (IPSS) exceeding 19 that remains unresponsive to combination drug therapy.
- Secondary Organ Complications: Formation of recurrent bladder stones, recurrent urinary tract infections (UTIs), or gross hematuria originating from enlarged prostatic vessels.
- Upper Tract Deterioration: Bilateral hydronephrosis or renal impairment caused by chronic high-pressure urinary retention.
- Significant Residual Urine: Post-void residual (PVR) volume consistently exceeding 100 to 150 mL with progressive detrusor decompensation.
2. Surgical Selection Framework: Comparing Modern BPH Modalities
No single surgical technique suits every patient. Prostate volume, presence of an obstructive median lobe, anticoagulation status, and sexual preservation goals dictate the optimal approach.
- HoLEP (Holmium Laser Enucleation of the Prostate)
- Target Volume: Effective for all sizes, especially large glands.
- Mechanism: Complete anatomical enucleation of the adenoma using a high-energy holmium laser, followed by tissue morcellation.
- Advantages: Extremely low recurrence rates (under 1–2% over 10 years), minimal blood loss, and rapid symptom resolution.
Considerations: High incidence of retrograde ejaculation; requires advanced surgical technique.
Aquablation (Robotic Waterjet Resection)
- Target Volume: Suitable for glands ranging from all volume.
- Mechanism: Heat-free, robotic high-velocity saline jet ablation guided by real-time transrectal ultrasound.
- Advantages: Eliminates thermal injury, achieves high tissue removal precision, and significantly preserves sexual function (ejaculatory preservation rates exceeding 80–90% with hood-sparing techniques).
Considerations: Requires specialized robotic equipment and post-resection hemostasis monitoring.
UroLift (Prostatic Urethral Lift)
- Target Volume: Moderate glands below 80 mL without an obstructing median lobe.
- Mechanism: Permanent transprostatic implants retract obstructing lateral lobes to mechanically widen the urethra.
- Advantages: Zero thermal tissue destruction, 100% preservation of erectile and ejaculatory function, rapid recovery within 24–48 hours.
Considerations: Higher retreatment rate (reported around 5–10% at 5 years) compared to resective procedures.
Rezūm (Water Vapor Thermal Therapy)
- Target Volume: Glands between 30 and 80 mL, including those with median lobe enlargement.
- Mechanism: Targeted convective water vapor injections deliver thermal energy, causing localized cell death and gradual tissue reabsorption over several weeks.
- Advantages: Minimally invasive, can be performed under local/regional anesthesia, high rate of sexual function preservation.
Considerations: Slower symptom improvement, requiring a temporary catheter for several days post-procedure due to initial tissue edema.
iTind (Temporarily Implanted Nitinol Device)
- Target Volume: Small to moderate glands (under 40–50 mL) in younger patients.
- Mechanism: A temporary nitinol basket expands in the prostatic urethra for 5–7 days, creating ischemic incisions at the bladder neck before removal.
- Advantages: Completely tissue-sparing, preserves total sexual function, zero permanent implants.
- Considerations: Limited to selected anatomical configurations.
3. Anesthesia, Recovery, and Same-Day Discharge Workflow
Modern surgical facilities in Incheon utilize regional anesthesia techniques to replace traditional general anesthesia.
- Specialized Pelvic and Caudal Anesthesia: Targeted caudal or saddle block regional anesthesia provides complete sensory blockage of the pelvic floor without profound hemodynamic instability. This approach avoids the headaches, prolonged bed rest, and respiratory risks associated with conventional general anesthesia.
- Rapid Ambulation Protocol: Patients typically regain lower extremity sensation within 2 to 3 hours post-procedure, allowing same-day ambulation and discharge.
- Catheter Management: Depending on the modality, catheters are often removed within 24 hours. Minimally invasive tissue-sparing techniques allow immediate voiding trials before discharge.
4. Postoperative Red Flags and Escalation Protocol
While modern endoscopic techniques show favorable safety profiles, patients should understand expected physiological healing versus urgent complications:
- Expected Symptoms: Transient mild dysuria, light hematuria, urinary urgency, and perineal tightness during the initial 1 to 2 weeks.
- Immediate Escalation Required (Red Flags):
- Fever: Core body temperature exceeding 38.0°C (100.4°F), indicating potential urosepsis or acute prostatitis.
- Clot Retention: Inability to void accompanied by severe suprapubic pain, signaling blood clots obstructing the urethra.
- Continuous Bright Red Hematuria: Unabating heavy bleeding that does not clear with increased hydration and rest.
5. Advanced Clinical Capabilities in Incheon
Managing complex urological cases requires both precise diagnostic tools and versatile surgical systems. Facilities in regional medical centers such as the Incheon (Guwol-dong) district integrate university-grade diagnostic and operative systems into high-throughput outpatient centers.
Key infrastructure includes:
* High-Powered 120H Holmium Laser Units: Ensuring stable laser output and rapid enucleation for massive prostates exceeding 100 mL.
* AI-Assisted Diagnostic Ultrasonography and Urodynamic Suites: Measuring detrusor contractility and exact structural parameters before selecting a surgical technique.
* Multi-Modal Surgical Capabilities: Equipping all major contemporary modalities—including HoLEP, robotic Aquablation, Rezūm, UroLift, and Plasma TURIS—under standardized surgical protocols.
* Rapid Multi-PCR Screening: Identifying subclinical urethral and prostatic bacterial strains prior to instrumentation to eliminate post-surgical infection risks.
Expert Clinical Commentary
Dr. Changgi Lee from Goldman Urology Clinic stated, “Surgical treatment for Benign Prostatic Hyperplasia must never rely on a one-size-fits-all approach. Every prostate presents a distinct anatomical shape, volume, and vascularity. By analyzing individual gland morphology with high-resolution imaging and utilizing the complete spectrum of advanced modalities—from 120H Holmium laser enucleation to robotic Aquablation—we can effectively relieve urinary obstruction while actively preserving sexual function and ensuring same-day recovery for patients in Incheon.”
For more clinical information, visit: http://gold-man.com